FDA approves first generic versions of celecoxib
The U.S. Food and Drug Administration today approved the first generic versions of Celebrex (celecoxib) capsules, a treatment for rheumatoid arthritis, osteoarthritis, short-term (acute) pain, and other conditions.
Source: Food and Drug Administration - Category: American Health Source Type: news
More News: American Health | Arthritis | Celebrex | Food and Drug Administration (FDA) | Osteoarthritis | Pain | Rheumatoid Arthritis | Rheumatology